The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEbiquity Regulatory News (EBQ)

Share Price Information for Ebiquity (EBQ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 2.00 (5.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 41.00
EBQ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Postponement of Results and COVID 19 update

24 Mar 2020 07:00

RNS Number : 2934H
Ebiquity PLC
24 March 2020
 

Ebiquity PLC

 

("Ebiquity" or "the Company")

 

Postponement of Results and COVID 19 update

 

Following the request by the FCA that all listed companies observe a moratorium on the publication of preliminary financial statements for at least two weeks, the preliminary results for Ebiquity will be delayed from the previously planned date of publication on Thursday 26th March 2020. Notification of a new publication date will follow when further guidance from the FCA and other regulatory authorities is available.

 

Ebiquity's global business is continuing to deliver services to clients as usual, with staff in most of our offices worldwide now working remotely, supported by our global IT systems. We are pleased though that our staff in China and Singapore are now returning to office-based working.

 

As previously announced on 19 February 2020, Ebiquity's trading for the year ended 31 December 2019 was in line with expectations with the second half performance trend similar to the first half of the year. Whilst the audit is not yet complete, if announcing preliminary results today, Ebiquity would be expecting to report, on a going concern basis, revenue of £68.7 million and Adjusted Operating Profit of £6.2 million.

 

Following the disposal of Ad Intel in January 2019, Ebiquity has a considerably stronger balance sheet. Net debt at 31 December 2019 was £5.8 million, (compared to £28 million prior to the disposal of Ad Intel). At that date, its cash balances were £8.2m. The Group has committed banking facilities of £24 million, whose maturity date is in 2023, of which £14 million was drawn down as at 31 December 2019.

 

Trading in the current year has started in line with the Board's expectations. However, the rapidly developing Covid-19 global outbreak is clearly creating uncertainty over the coming months for our clients' businesses, which cover many sectors and geographies, as well as our own. The Board therefore believes it prudent at this stage to withdraw guidance on the Group's overall performance in 2020.

 

Rob Woodward, Chairman commented:

 

"We are extremely proud of all of our staff who have shown great resilience and flexibility in responding to the challenges of the Covid-19 outbreak. The Board thanks all Ebiquity's global teams for their continued commitment and determination to deliver high quality professional service and independent media advice to our clients during this difficult time."

 

 

Enquiries:

 

Ebiquity plc

Alan Newman (Interim Chief Executive Officer)

Mark Sanford (Company Secretary)

 

Via Instinctif Partners

 

Instinctif Partners

Matthew Smallwood

Guy Scarborough

 

020 7457 2020

Numis Securities Limited

Nick Westlake (NOMAD)

Matt Lewis

020 7260 1000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDDGGDXSUDDGGX
Date   Source Headline
25th Mar 20197:00 amRNSUnaudited Preliminary Results
1st Mar 20192:15 pmRNSTotal Voting Rights
22nd Feb 20193:55 pmRNSIssue of Shares
18th Feb 20197:00 amRNSHolding(s) in Company
12th Feb 20197:00 amRNSPre-close Trading Update
1st Feb 20197:00 amRNSTotal Voting Rights
23rd Jan 20194:50 pmRNSReplacement: Issue of Shares
23rd Jan 20193:25 pmRNSIssue of Shares
14th Jan 20193:35 pmRNSIssue of Shares
3rd Jan 20192:55 pmRNSIssue of Shares
2nd Jan 201911:40 amRNSDirectorate Change
2nd Jan 201911:40 amRNSCompletion of the disposal of the AdIntel division
2nd Jan 20197:00 amRNSTotal Voting Rights
14th Dec 20187:00 amRNSDirectorate Change
5th Dec 20181:45 pmRNSIssue of Shares
22nd Nov 20187:00 amRNSTrading Update
22nd Nov 20187:00 amRNSStatement re CMA final clearance notification
1st Nov 20187:00 amRNSTotal Voting Rights
24th Oct 20182:40 pmRNSIssue of Shares
23rd Oct 20182:05 pmRNSHolding(s) in Company
18th Oct 20184:06 pmRNSIssue of Shares
15th Oct 20187:00 amRNSIssue of Shares
11th Oct 20187:10 amRNSStatement re CMA Provisional Findings
10th Oct 201812:15 pmRNSDirectorate Change
4th Oct 20187:00 amRNSDirector/PDMR Shareholding
2nd Oct 20187:00 amRNSDirectorate Change
1st Oct 20187:00 amRNSTotal Voting Rights
27th Sep 20189:10 amRNSIssue of Shares
25th Sep 20187:00 amRNSDirectorate Change
25th Sep 20187:00 amRNSInterim Results
3rd Aug 20188:51 amRNSDirector/PDMR Shareholding
1st Aug 20187:00 amRNSTotal Voting Rights
27th Jul 20188:59 amRNSHolding(s) in Company
27th Jul 20188:55 amRNSHolding(s) in Company
27th Jul 20187:00 amRNSIssue of Shares and Director/PDMR Shareholdings
24th Jul 20187:00 amRNSInterim Trading Update
20th Jul 20185:00 pmRNSHolding(s) in Company
11th Jul 20183:05 pmRNSAward of options
6th Jul 20183:00 pmRNSIssue of Shares
25th Jun 20187:15 amRNSStatement re CMA Phase 2 referral
15th Jun 20187:00 amRNSPartnership with Snapchat to enhance measurement
13th Jun 20187:05 amRNSStatement re CMA review of disposal
1st Jun 20189:15 amRNSTotal Voting Rights
18th May 201812:20 pmRNSHolding(s) in Company
9th May 201812:11 pmRNSAGM Resolutions Passed
9th May 20187:00 amRNSIssue of Shares
1st May 20181:10 pmRNSHolding(s) in Company
27th Apr 20187:00 amRNSDirector/PDMR Shareholding
13th Apr 20187:00 amRNSAnnual Report
12th Apr 20182:15 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.